Chemomab Therapeutics Ltd. (CMMB)

CIK 1534248 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Chemomab Therapeutics Ltd..

Recent SEC filings

FiledFormAccession number
Nov 3, 20266-K0001178913-26-004976
Oct 30, 2026DEFM14A0001493152-26-049444
Oct 30, 2026EFFECT9999999995-26-003389
Oct 29, 2026S-4/A0001493152-26-049306
Oct 19, 2026S-4/A0001493152-26-047625
Oct 19, 20266-K0001178913-26-004796
Sep 30, 20266-K0001178913-26-004676
Sep 25, 2026S-40001493152-26-044397
Sep 9, 2026SCHEDULE 13D/A0001104659-26-106301
Sep 1, 202640001178913-26-004371
Aug 19, 20266-K0001178913-26-004193
Aug 13, 2026SCHEDULE 13G0002148623-26-000001
Aug 10, 2026SCHEDULE 13G/A0001995601-26-000004
Jul 16, 2026SCHEDULE 13D0001104659-26-084244
Jul 8, 20266-K0001178913-26-003442
Jun 3, 202630001178913-26-003083
Jun 2, 20266-K0001178913-26-003058
Jun 1, 202640001178913-26-003004
May 14, 20266-K0001178913-26-002672
May 6, 20266-K0001178913-26-002423
Apr 28, 20266-K0001178913-26-002274
Apr 10, 202630001178913-26-002068
Apr 10, 202630001178913-26-002062
Apr 10, 202630001178913-26-002066
Apr 10, 202630001178913-26-002064